Oscar Health, Inc.
Every calculator, already run for OSCR
Open the full toolkit →You have the numbers on OSCR. Get the argument.
A written report on which of these readings actually decide the outcome for Oscar Health, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
11 analysts covering OSCRAnalyst Price Target Disagreement for Oscar Health, Inc.
Wall Street's bull case implies +58% from the current price; the bear case implies -16%. A 74% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for OSCR
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Oscar Health, Inc.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorp…
OSCR — frequently asked
Is OSCR a buy right now?
Wall Street's consensus rating on Oscar Health, Inc. is Hold across 11 analysts, with a mean price target of $35.40 (+14% vs. the current $30.94). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is OSCR overvalued?
OSCR trades at 24.0x trailing earnings, against a DCF fair value of $25 per share. The current price implies 10% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is OSCR's next earnings date?
Oscar Health, Inc. is next scheduled to report earnings around Nov 9, 2026. A full OSCR research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Oscar Health, Inc.?
Analysts covering Oscar Health, Inc. (OSCR) range from a bear-case target of $26.00 to a bull-case high of $49.00, with a mean consensus target of $35.40 across 10 analysts. The spread of $23.00 (74% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Oscar Health, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Oscar Health, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full OSCR research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Oscar Health, Inc., in minutes. 3 free reports included with every account — no credit card required.